Prothena Corp Public (PRTA) Other financing activities (2012 - 2024)
Prothena Corp Public's (PRTA) quarterly Other financing activities came in at -$1000.0 in Q4 2024, down 100.18% year-on-year from $548000.0 in Q1 2024, and down 100.23% quarter-over-quarter from $427000.0 in Q3 2024.
Prothena Corp Public (PRTA) Other financing activities (2012 - 2024) Analysis & Trends
Prothena Corp Public's Other financing activities history runs 12 years deep, the most recent figure standing at -$1000.0 for Q4 2024.
- On a quarterly basis, Other financing activities fell 100.18% year-over-year to -$1000.0 in Q4 2024; TTM through Sep 2025 was -$1000.0, a 100.04% decrease from a year earlier, with the FY2024 full-year figure at $1.9 million, down 91.14% from the prior year.
- Other financing activities fell to -$1000.0 in Q4 2024 per PRTA's latest filing, from $427000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $15.6 million in Q2 2023 and bottomed at -$1000.0 in Q4 2024.
- The 5-year median for Other financing activities is $1.7 million (2021), against an average of $3.2 million.
- Across the five-year window, Other financing activities jumped 6368.75% in 2021 and sank 100.18% in 2024, its largest moves.
- Year by year, Other financing activities stood at $64000.0 in 2020, then soared by 2790.62% to $1.8 million in 2021, then soared by 528.7% to $11.6 million in 2022, then plunged by 95.29% to $548000.0 in 2023, then sank by 100.18% to -$1000.0 in 2024.
- Per Business Quant, the three latest PRTA Other financing activities figures stand at -$1000.0 (Q4 2024), $427000.0 (Q3 2024), and $591000.0 (Q2 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Prothena Corp Public | 458.13 Mn | 128.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Sep 30, 2024 | 427,000.00 |
| Sep 30, 2024 | 427,000.00 |
| Jun 30, 2024 | 591,000.00 |
| Jun 30, 2024 | 591,000.00 |
| Mar 31, 2024 | 890,000.00 |
| Mar 31, 2024 | 890,000.00 |
| Dec 31, 2023 | 548,000.00 |
| Dec 31, 2023 | 548,000.00 |
| Sep 30, 2023 | 2.78 Mn |
| Sep 30, 2023 | 2.78 Mn |
| Jun 30, 2023 | 15.59 Mn |
| Jun 30, 2023 | 15.59 Mn |
| Mar 31, 2023 | 2.60 Mn |
| Mar 31, 2023 | 2.60 Mn |
| Dec 31, 2022 | 11.63 Mn |
| Dec 31, 2022 | 11.63 Mn |
| Sep 30, 2022 | 4.30 Mn |
| Sep 30, 2022 | 4.30 Mn |